How to Get Breyanzi Covered by UnitedHealthcare in Ohio: Complete Prior Authorization Guide (2025)
Answer Box: Your Fastest Path to Breyanzi Coverage
Breyanzi (lisocabtagene maraleucel) requires prior authorization from UnitedHealthcare in Ohio. Your oncologist must submit clinical documentation showing you meet FDA-approved criteria for relapsed/refractory large B-cell lymphoma (≥2 prior lines) or CLL/SLL (after BTK and BCL-2 inhibitor failure). Standard review takes 72 hours; expedited review 24 hours for urgent cases.
First step today: Contact your treatment center to confirm they're UnitedHealthcare credentialed for CAR-T therapy and ask them to begin the PA submission through the UnitedHealthcare Provider Portal.
Table of Contents
- Coverage Basics
- Prior Authorization Process
- Timing and Deadlines
- Medical Necessity Criteria
- Cost Considerations
- Denials and Appeals
- Specialty Pharmacy Requirements
- Ohio-Specific Appeal Rights
- Common Questions
- Resources and Next Steps
Coverage Basics
Is Breyanzi Covered by UnitedHealthcare?
Yes, Breyanzi is covered under UnitedHealthcare's oncology medication policy when medically necessary and administered at certified treatment centers. Coverage applies across commercial plans, Medicare Advantage, and Medicaid managed care in Ohio.
Which UnitedHealthcare Plans Cover Breyanzi?
- Commercial/Employer Plans: Covered with prior authorization
- Medicare Advantage: Follows Medicare NCD 110.24 for CAR-T therapies
- Medicaid Managed Care: Covered under transplantation services benefit
- Exchange/Marketplace Plans: Prior authorization required
Note: Self-funded employer plans may have different requirements. Check with your HR benefits team about your specific coverage.
Prior Authorization Process
Step-by-Step: Fastest Path to Approval
- Confirm Treatment Center Credentialing (Day 1)
- Use the Breyanzi treatment center locator to find certified centers in Ohio
- Verify the center is in UnitedHealthcare's specialty network
- Confirm they can handle CAR-T REMS requirements
- Gather Required Documentation (Days 1-2)
- Complete medical records showing disease progression
- Laboratory values (CBC, CMP, liver function)
- Cardiac function assessment (ECHO or MUGA)
- Documentation of prior therapy failures
- Submit Prior Authorization (Day 3)
- Provider submits through UnitedHealthcare Provider Portal
- Alternative: OptumRx PA line at 888-397-8129
- Mark "EXPEDITED REVIEW REQUESTED" if urgent
- Track Status (Days 4-5)
- Check portal for status updates
- Respond to any information requests within 24-48 hours
Who Submits the Prior Authorization?
Your oncologist or treatment center submits the PA request—patients cannot submit directly. However, you can:
- Ask your provider about submission status
- Request expedited review if medically urgent
- Provide additional clinical information if requested
Timing and Deadlines
Standard Review Timeline
| Review Type | Timeline | When to Use |
|---|---|---|
| Standard PA | 72 hours | Non-urgent cases |
| Expedited PA | 24 hours | Urgent medical need |
| Additional info response | 14 days given, 24-48 hours recommended | Information requests |
When to Request Expedited Review
Request expedited review when:
- Disease progression threatens immediate health
- Delay could compromise treatment effectiveness
- Patient's condition is rapidly deteriorating
Tip: Include specific clinical reasoning for urgency in your expedited request—general statements aren't sufficient.
Medical Necessity Criteria
Coverage at a Glance
| Requirement | LBCL Criteria | CLL/SLL Criteria | Documentation Needed |
|---|---|---|---|
| Line of therapy | ≥2 prior systemic therapies | ≥2 prior lines including BTK + BCL-2 inhibitors | Treatment history, dates, responses |
| Disease status | Relapsed or refractory | Relapsed or refractory | Imaging, labs showing progression |
| Performance status | ECOG 0-2 (typical) | ECOG 0-2 (typical) | Provider assessment |
| Organ function | Adequate cardiac, hepatic, renal | Adequate cardiac, hepatic, renal | Recent lab values, ECHO/MUGA |
| Facility requirement | REMS-certified center | REMS-certified center | Center credentialing verification |
Clinician Corner: Medical Necessity Letter Checklist
Healthcare providers should include:
Clinical Documentation:
- Primary diagnosis with ICD-10 codes
- Complete treatment history with dates, drugs, doses, and outcomes
- Evidence of refractoriness or relapse within 12 months of first-line therapy
- Current disease status with recent imaging/labs
Supporting Evidence:
- FDA-approved labeling for Breyanzi indications
- NCCN Guidelines supporting CAR-T use in relapsed/refractory setting
- Patient-specific factors supporting treatment choice
Cost Considerations
Understanding Your Out-of-Pocket Costs
Breyanzi's wholesale acquisition cost ranges from $447,000 to $487,000, with total treatment costs potentially exceeding $800,000 when including:
- Pre-treatment workup and lymphodepletion
- Inpatient monitoring for toxicity management
- Post-treatment supportive care
Financial Assistance Options
Manufacturer Support:
- Bristol Myers Squibb Access Support provides patient assistance programs
- Contact: Visit breyanzi.com for current program details
Foundation Grants:
- Leukemia & Lymphoma Society Patient Aid Program
- CancerCare Financial Assistance Program
- HealthWell Foundation (when funds available)
Important: Apply for financial assistance programs early—many have limited annual funding.
Denials and Appeals
Common Denial Reasons & How to Overturn Them
| Denial Reason | How to Address | Required Documentation |
|---|---|---|
| Insufficient prior therapy | Document all previous treatments with dates and outcomes | Complete treatment timeline, provider notes |
| Performance status concerns | Provide current ECOG assessment with clinical justification | Recent clinic visit notes, functional status evaluation |
| Non-credentialed facility | Transfer to certified CAR-T center | Confirmation of REMS certification |
| Missing laboratory values | Submit current labs within normal ranges | CBC, CMP, LFTs dated within 30 days |
Appeals Playbook for UnitedHealthcare in Ohio
Internal Appeals Process:
- First Level Internal Appeal
- File within 180 days of denial
- Submit through UnitedHealthcare Provider Portal or mail to address on denial letter
- Include point-by-point response to denial reasons
- Timeline: 30 days for standard, 72 hours for expedited
- Second Level Internal Appeal (if needed)
- Automatic if first level upheld
- Independent medical review
- Timeline: 30 days for standard, 72 hours for expedited
Ohio External Review Process: After exhausting internal appeals, you have the right to external review through the Ohio Department of Insurance:
- File within: 180 days of final internal denial
- Process: Independent Review Organization (IRO) conducts medical review
- Timeline: 30 days standard, 72 hours expedited
- Decision: Binding on UnitedHealthcare
- Contact: Ohio DOI Consumer Services at 1-800-686-1526
Specialty Pharmacy Requirements
Why Breyanzi Requires Special Handling
Breyanzi is only available through:
- REMS-certified treatment centers
- Facilities credentialed for CAR-T administration
- Centers with trained staff for managing cytokine release syndrome
Counterforce Health helps patients navigate complex specialty pharmacy requirements by identifying the right treatment centers and ensuring all documentation meets payer-specific criteria for approval.
Finding Certified Centers in Ohio
Use the official Breyanzi treatment center locator to identify certified facilities. Major academic medical centers in Ohio typically offer CAR-T programs, but verify:
- UnitedHealthcare network participation
- Current REMS certification status
- Availability for your treatment timeline
Ohio-Specific Appeal Rights
What Makes Ohio Different
Ohio provides strong consumer protections for insurance appeals:
Extended Timeline: You have 180 days (6 months) to request external review—longer than many states
Independent Determination: Even if UnitedHealthcare claims your case isn't eligible for external review, the Ohio Department of Insurance can independently determine eligibility
Binding Decisions: External review decisions are binding on your insurer—if approved, UnitedHealthcare must cover the treatment
Getting Help in Ohio
- Ohio Department of Insurance Consumer Services: 1-800-686-1526
- UHCAN Ohio (Universal Health Care Action Network): Provides consumer assistance with appeals
- OSHIIP (Ohio Senior Health Insurance Information Program): For Medicare-related issues
Common Questions
How long does UnitedHealthcare PA take in Ohio? Standard review is 72 hours from complete submission. Expedited review for urgent cases is 24 hours. Additional information requests extend the timeline.
What if Breyanzi is non-formulary on my plan? Breyanzi coverage is typically evaluated under medical benefits rather than pharmacy formulary. Your provider can request a medical necessity review regardless of formulary status.
Can I request an expedited appeal? Yes, if delay would seriously jeopardize your health or ability to regain maximum function. Include specific clinical reasoning for urgency.
Does step therapy apply if I've tried treatments outside Ohio? Yes, UnitedHealthcare recognizes prior therapies regardless of where they were administered. Provide complete documentation of all previous treatments.
What happens if my treatment center isn't in-network? Request a network adequacy exception if no in-network certified CAR-T centers are available within a reasonable distance. UnitedHealthcare may authorize out-of-network treatment at in-network rates.
Resources and Next Steps
Immediate Action Items
- Contact your oncologist to discuss Breyanzi eligibility and begin PA process
- Verify treatment center network status and REMS certification
- Gather documentation of prior therapies and current disease status
- Apply for financial assistance programs while PA is pending
Key Contacts
- UnitedHealthcare Provider Services: Use provider portal or call number on your insurance card
- OptumRx Prior Authorization: 888-397-8129
- Ohio Department of Insurance: 1-800-686-1526
- Breyanzi Treatment Center Locator: breyanzi.com/find-a-treatment-center
From Our Advocates: We've seen patients successfully appeal Breyanzi denials by providing comprehensive documentation of treatment failures and working closely with certified CAR-T centers to address specific payer concerns. The key is thorough preparation and persistence through the appeals process.
At Counterforce Health, we specialize in turning insurance denials into targeted, evidence-backed appeals. Our platform helps patients and clinicians navigate complex prior authorization requirements by identifying specific denial reasons and drafting point-by-point rebuttals aligned with payer policies.
Sources & Further Reading
- UnitedHealthcare Oncology Medication Clinical Coverage Policy
- Ohio Medicaid CAR-T Coverage Policy
- UnitedHealthcare Appeals Process
- Ohio Department of Insurance External Review
- Breyanzi FDA Prescribing Information
Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions depend on individual circumstances and plan terms. Always consult with your healthcare provider and insurance company for personalized guidance. For questions about Ohio insurance regulations, contact the Ohio Department of Insurance at 1-800-686-1526.
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.